Exact Mass: 500.2808
Exact Mass Matches: 500.2808
Found 500 metabolites which its exact mass value is equals to given mass value 500.2808
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mupirocin
Mupirocin (pseudomonic acid A, or Bactroban or Centany) is an antibiotic originally isolated from Pseudomonas fluorescens. It is used topically, and is primarily effective against Gram-positive bacteria. Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. Mupirocin has a unique mechanism of action, which is selective binding to bacterial isoleucyl-tRNA synthetase, which halts the incorporation of isoleucine into bacterial proteins. Because this mechanism of action is not shared with any other antibiotic, mupirocin has few problems of antibiotic cross-resistance. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Same as: D01076 Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].
Tuftsin
Tuftsin (L-threonyl-L-lysyl-L-prolyl-L-arginine) is a peptide related primarily to the immune system function. Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) produced by enzymatic cleavage of the Fc-domain of the heavy chain of immunoglobulin G. It is produced primarily in the spleen. Its biological activity is related primarily to the immune system function. Tuftsin binds to specific receptors on the surface of macrophages and polymorphonuclear leukocytes, stimulating their migration, phagocytic, bactericidal, and tumoricidal activity. It also influences antibody formation. Tuftsin deficiency, either hereditary or following splenectomy, results in increased susceptibility to certain infections. Tuftsin has been chemically synthesized and it is considered for use in immunotherapy. [HMDB] Tuftsin (L-threonyl-L-lysyl-L-prolyl-L-arginine) is a peptide related primarily to the immune system function. Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) produced by enzymatic cleavage of the Fc-domain of the heavy chain of immunoglobulin G. It is produced primarily in the spleen. Its biological activity is related primarily to the immune system function. Tuftsin binds to specific receptors on the surface of macrophages and polymorphonuclear leukocytes, stimulating their migration, phagocytic, bactericidal, and tumoricidal activity. It also influences antibody formation. Tuftsin deficiency, either hereditary or following splenectomy, results in increased susceptibility to certain infections. Tuftsin has been chemically synthesized and it is considered for use in immunotherapy.
Kentsin
Kentsin is a contraceptive peptide first isolated from female hamsters. [HMDB] Kentsin is a contraceptive peptide first isolated from female hamsters.
Laprafylline
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator
Adavosertib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors
9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid
3,15-Dihydroxy-ent-labd-7-en-oic acid 3-O-beta-D-glucoside
ent-8R,13S;15,17-diepoxy-3beta-D-glucopyranosyloxylabdan-14alpha-ol|microtropioside A
(6R,7E,9R)-9-hydroxy-4,7-megastigmadien-3-one 9-O-[alpha-L-arabinopyranosyl-(1 -> 6)-beta-D-glucopyranoside]
9-Hydroxy-gamma-geraniol-1-O-<4,6-diacetyl-3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-[4,6-diacetyl-3-(2-methylbutanoyl)]-beta-D-glucopyranoside
9-Acetoxy-gamma-geraniol-1-O-<6-acetyl-3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-[6-acetyl-3-(2-methylbutanoyl)]-beta-D-glucopyranoside
(5alpha,6beta,18S,22R)-18,20-epoxy-5,6,22-trihydroxy-18-methoxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone|withaphysalin R
16-O-beta-D-Glucopyranoside-(ent-3beta, 13xi)-7-Pimarene-3, 15, 16, 18-tetrol
14beta-acetoxy-3beta-benzoyloxy-7beta,9alpha,15beta-trihydroxyjatropha-5E,11E-diene|euphoheliosnoid F
1-benzoyl-8,8-dimethyl-3,5-bis(3-methyl-2-butenyl)-6-(2-methylpropenyl)tricyclo[3.3.1.1(3.7)]-decan2-2,4,9-trione|plukenetione A
ent-2beta,15,16,19-tetrahydroxypimar-8(14)-en-19-O-beta-glucopyranoside
(1beta,5beta,8xi,9beta,10alpha,11alpha,14beta)-8,11,14-trihydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside A
(3S,5S,10S,11S,13R,16R,17S,20S,22R,23S,24S)-16,22-epoxy-21,23-lactone-3,11,24-trihydroxystigmasta-8,14-dien-28-one|vernoanthelcin E
(2beta,3Z,7alpha,8E)-3,8-Dolabelladiene-2,7,16,18-tetrol|chrozophorozide B
3beta-O-(beta-D-2-deoxy-rhamnosyl)-8,14beta-epoxy-5beta-carda-16,20(22)-dienolide|dehydroadynerizoside
12beta,16alpha,17,19-tetrahydroxy-ent-kaurane 19-O-beta-D-glucopyranoside
2,3,16alpha,20-tetrahydroxy-29-norcucurbita-1,3,5(10),23(E)-tetraene-11,22-dione|desacetylfevicordin A
7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanosta-8-en-26-oic acid|ganoderic acid D
(13S)-ent-18-(E)-caffeoyloxy-7beta-hydroxy-3-cleroden-15-oic acid|ent-18-(E)-Caffeoyloxy-7??-hydroxy-3-cleroden-15-oic acid
Withaphysalin R
Mupirocin
An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].
4beta-deoxyphorbol 12-tiglate-13-isobutyrate (4-dPE A) / isolated from Euphorbia amygdaloides ssp. semiperfoliata
4alpha-deoxyphorbol 12-tiglate-13-isobutyrate (4a-dPE A) / isolated from Euphorbia amygdaloides ssp semiperfoliata
5-[3-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-5-hydroxypentyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
Glucoraphanin (4-methylsulfinylbutyl glucosinolate)
4-Methoxyglucobrassicin (4-Methoxy-3-indolylmethyl glucosinolate)
Neoglucobrassicin (1-Methoxy-3-indolylmethyl glucosinolate)
5-[3-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-5-hydroxypentyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid [IIN-based: Match]
Ala Lys Pro Trp
Ala Lys Trp Pro
Ala Pro Lys Trp
Ala Pro Trp Lys
Ala Trp Lys Pro
Ala Trp Pro Lys
Glu Lys Lys Pro
Glu Lys Pro Lys
Glu Lys Pro Gln
Glu Lys Gln Pro
Glu Pro Lys Lys
Glu Pro Lys Gln
Glu Pro Gln Lys
Glu Gln Lys Pro
Glu Gln Pro Lys
Phe His Val Val
Phe Val His Val
Phe Val Val His
His Phe Val Val
His Val Phe Val
His Val Val Phe
Ile Ile Gln Gln
Ile Leu Gln Gln
Ile Asn Arg Val
Ile Asn Val Arg
Ile Gln Ile Gln
Ile Gln Leu Gln
Ile Gln Gln Ile
Ile Gln Gln Leu
Ile Arg Asn Val
Ile Arg Val Asn
Ile Val Asn Arg
Ile Val Arg Asn
Lys Ala Pro Trp
Lys Ala Trp Pro
Lys Glu Lys Pro
Lys Glu Pro Lys
Lys Glu Pro Gln
Lys Glu Gln Pro
Lys Lys Glu Pro
Lys Lys Pro Glu
Lys Pro Ala Trp
Lys Pro Glu Lys
Lys Pro Glu Gln
Lys Pro Lys Glu
Lys Pro Gln Glu
Lys Pro Arg Thr
Lys Pro Thr Arg
Lys Pro Trp Ala
Lys Gln Glu Pro
Lys Gln Pro Glu
Lys Arg Pro Thr
Lys Arg Thr Pro
Lys Thr Pro Arg
Lys Thr Arg Pro
Lys Trp Ala Pro
Lys Trp Pro Ala
Leu Ile Gln Gln
Leu Leu Gln Gln
Leu Asn Arg Val
Leu Asn Val Arg
Leu Gln Ile Gln
Leu Gln Leu Gln
Leu Gln Gln Ile
Leu Gln Gln Leu
Leu Arg Asn Val
Leu Arg Val Asn
Leu Val Asn Arg
Leu Val Arg Asn
Asn Ile Arg Val
Asn Ile Val Arg
Asn Leu Arg Val
Asn Leu Val Arg
Asn Arg Ile Val
Asn Arg Leu Val
Asn Arg Val Ile
Asn Arg Val Leu
Asn Val Ile Arg
Asn Val Leu Arg
Asn Val Arg Ile
Asn Val Arg Leu
Pro Ala Lys Trp
Pro Ala Trp Lys
Pro Glu Lys Lys
Pro Glu Lys Gln
Pro Glu Gln Lys
Pro Lys Ala Trp
Pro Lys Glu Lys
Pro Lys Glu Gln
Pro Lys Lys Glu
Pro Lys Gln Glu
Pro Lys Arg Thr
Pro Lys Thr Arg
Pro Lys Trp Ala
Pro Gln Glu Lys
Pro Gln Lys Glu
Pro Gln Arg Thr
Pro Gln Thr Arg
Pro Arg Lys Thr
Pro Arg Gln Thr
Pro Arg Thr Lys
Pro Arg Thr Gln
Pro Thr Lys Arg
Pro Thr Gln Arg
Pro Thr Arg Lys
Pro Thr Arg Gln
Pro Trp Ala Lys
Pro Trp Lys Ala
Gln Glu Lys Pro
Gln Glu Pro Lys
Gln Ile Ile Gln
Gln Ile Leu Gln
Gln Ile Gln Ile
Gln Ile Gln Leu
Gln Lys Glu Pro
Gln Lys Pro Glu
Gln Leu Ile Gln
Gln Leu Leu Gln
Gln Leu Gln Ile
Gln Leu Gln Leu
Gln Pro Glu Lys
Gln Pro Lys Glu
Gln Pro Arg Thr
Gln Pro Thr Arg
Gln Gln Ile Ile
Gln Gln Ile Leu
Gln Gln Leu Ile
Gln Gln Leu Leu
Gln Arg Pro Thr
Gln Arg Thr Pro
Gln Arg Val Val
Gln Thr Pro Arg
Gln Thr Arg Pro
Gln Val Arg Val
Gln Val Val Arg
Arg Ile Asn Val
Arg Ile Val Asn
Arg Lys Pro Thr
Arg Lys Thr Pro
Arg Leu Asn Val
Arg Leu Val Asn
Arg Asn Ile Val
Arg Asn Leu Val
Arg Asn Val Ile
Arg Asn Val Leu
Arg Pro Lys Thr
Arg Pro Gln Thr
Arg Pro Thr Lys
Arg Pro Thr Gln
Arg Gln Pro Thr
Arg Gln Thr Pro
Arg Gln Val Val
Arg Thr Lys Pro
Arg Thr Pro Lys
Arg Thr Pro Gln
Arg Thr Gln Pro
Arg Val Ile Asn
Arg Val Leu Asn
Arg Val Asn Ile
Arg Val Asn Leu
Arg Val Gln Val
Arg Val Val Gln
Thr Lys Pro Arg
Thr Lys Arg Pro
Thr Pro Lys Arg
Thr Pro Gln Arg
Thr Pro Arg Lys
Thr Pro Arg Gln
Thr Gln Pro Arg
Thr Gln Arg Pro
Thr Arg Lys Pro
Thr Arg Pro Lys
Thr Arg Pro Gln
Thr Arg Gln Pro
Val Phe His Val
Val Phe Val His
Val His Phe Val
Val His Val Phe
Val Ile Asn Arg
Val Ile Arg Asn
Val Leu Asn Arg
Val Leu Arg Asn
Val Asn Ile Arg
Val Asn Leu Arg
Val Asn Arg Ile
Val Asn Arg Leu
Val Gln Arg Val
Val Gln Val Arg
Val Arg Ile Asn
Val Arg Leu Asn
Val Arg Asn Ile
Val Arg Asn Leu
Val Arg Gln Val
Val Arg Val Gln
Val Val Phe His
Val Val His Phe
Val Val Gln Arg
Val Val Arg Gln
Trp Ala Lys Pro
Trp Ala Pro Lys
Trp Lys Ala Pro
Trp Lys Pro Ala
Trp Pro Ala Lys
Trp Pro Lys Ala
Tuftsin acetate salt
Tuftsin is a tetrapeptide. Tuftsin is a macrophage/microglial activator.
tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl] orthoborate
lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
4-[bis(5-cyclohexyl-4-hydroxy-2-methylphenyl)methyl]benzene-1,2-diol
[2S,3S,5S]-2-Amino-3-hydroxy-5-tert-butyloxycarbonylamino-1,6-diphenylhexane fumarate salt
2-benzofuran-1,3-dione,2-ethylhexan-1-ol,hexanedioic acid,propane-1,2-diol
6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid
MK-1775
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors
N-arachidonoyl-sn-glycero-3-phosphoethanolamine(1-)
[(2R,3R,4R,5R)-2-[(1S,2R,3R,4S,6R)-4,6-bis(azaniumyl)-3-[(2R,3R,4S,5S,6R)-6-(1-azaniumylethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxy-5-methyloxan-4-yl]-methylazanium
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid
9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid
N-[(1R)-2-amino-2-oxo-1-phenylethyl]-N(2)-(diphenylacetyl)-D-argininamide
Norcholyltaurine(1-)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
1-(3-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
1-(2-fluorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
1-(2-fluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
Cyclopentanepropanoic acid, 3,5-bis(acetyloxy)-2-[3,8-bis(acetyloxy)octyl]-, methyl ester
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
1-(3-fluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-[(1S,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
1-(2-fluorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
2-[(1R,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide
(16R,17S)-8-(4-Morpholinyl)-17-[2-(4-morpholinyl)-2-oxoethyl]-12-oxa-1,4-diazatricyclo[14.3.1.06,11]icosa-6,8,10-trien-2-one
[(1R,2R,6S,10S,11R,13S,14R,15R)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-13-(2-methylpropanoyloxy)-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] (E)-2-methylbut-2-enoate
[(1R,2R,6R,10S,11R,13S,14R,15R)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-13-(2-methylpropanoyloxy)-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] (E)-2-methylbut-2-enoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
5-[3-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-5-hydroxypentyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
(1s,3r,4ar,6r,6as,6bs,7ar,10s,10as,12ar,12bs)-10-(furan-3-yl)-3,6-dihydroxy-4,4,6a,10a,12b-pentamethyl-8-oxo-dodecahydrochryseno[4,4a-b]oxiren-1-yl acetate
2-({4-hydroxy-1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4r,5r,6r)-3-(acetyloxy)-2-[(acetyloxy)methyl]-5-hydroxy-6-{[(6z)-8-hydroxy-7-methyl-3-methylideneoct-6-en-1-yl]oxy}oxan-4-yl (2r)-2-methylbutanoate
3-[(1s,3br,4r,9ar,11as)-4-(acetyloxy)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-oxopropyl acetate
(1s,3r,5r,7s,8r)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione
(1s,2r,4s,5r,6r,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-4-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
4-(2,4-dimethoxy-6-pentylbenzoyloxy)-2-heptyl-6-methoxybenzoic acid
1-(5-hydroxy-3-methylpentyl)-5,5,8a-trimethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid
2-hydroxy-5-methoxy-3-[(8z)-16-(2,3,5-trihydroxyphenyl)hexadec-8-en-1-yl]cyclohexa-2,5-diene-1,4-dione
4-{14-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0¹,³.0³,⁷.0¹¹,¹⁶]octadec-5-en-6-yl}-5h-furan-2-one
5-(acetyloxy)-2,6,10,10-tetramethyl-4-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione
2-{[14,15-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3s)-5-[(1r,2s,3r,4ar,8ar)-5-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3-hydroxy-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoic acid
(1s,9r,11r)-9-benzoyl-4,4,10,10-tetramethyl-1,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione
(2r,3r,4s,5s,6r)-2-{[(4r,4ar,4br,5r,7s,8r,8ar,10ar)-7-ethenyl-5,8,8a-trihydroxy-1,1,4a,7-tetramethyl-decahydrophenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[8-(acetyloxy)-7-methyl-3-methylideneoct-6-en-1-yl]oxy}-6-[(acetyloxy)methyl]-3,5-dihydroxyoxan-4-yl 2-methylbutanoate
14-[(4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-13-hydroxy-1,6,6,11,15-pentamethyl-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,7-diene-5,17-dione
1-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2,7,8-trihydroxy-3a,6,9b,11a-tetramethyl-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one
3,13-clerodadiene-6,15,16,19-tetrol; (ent-6β,13z)-form,19-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN006924","Ingredient_name": "3,13-clerodadiene-6,15,16,19-tetrol; (ent-6\u03b2,13z)-form,19-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H44O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8455","PubChem_id": "NA","DrugBank_id": "NA"}